Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First-line Treatment of Advanced Pancreatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT02024633
What this trial is testing

Combination of Icotinib and Gemcitabine as First-line Treatment in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Betta Pharmaceuticals Co., Ltd. 24
Testing effectiveness (Phase 2)Looking for participantsNCT05969171
What this trial is testing

A Single-center, Prospective, Two Cohort Study of Surufatinib Combined With AG or AG in the First-line Treatment of Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Metastatic
Fudan University 65
Testing effectiveness (Phase 2)Study completedNCT03443492
What this trial is testing

SLOG vs mFOLFIRINOX as the First-line Treatment in Locally Advanced Uncresectable or Metastatic Pancreatic Cancer

Who this might be right for
Locally Advanced or Metastatic Pancreatic Cancer
National Health Research Institutes, Taiwan 130
Not applicableLooking for participantsNCT06494514
What this trial is testing

NALIRIFOX Combined With PD-1 Sequential Radiotherapy Versus AG Combined With PD-1 Sequential Radiotherapy as First-line Treatment of Locally Advanced Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Cancer
Du Juan 40
Testing effectiveness (Phase 2)Ended earlyNCT01318642
What this trial is testing

Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas

Who this might be right for
Adenocarcinoma of the PancreasLocally AdvancedUnresectable
NantBioScience, Inc. 10
Testing effectiveness (Phase 2)UnknownNCT00003780
What this trial is testing

Chemotherapy Compared to Biological Therapy in Treating Patients With Cancer of the Pancreas

Who this might be right for
Pancreatic Cancer
Meyer Pharmaceuticals 150
Testing effectiveness (Phase 2)Looking for participantsNCT06736717
What this trial is testing

Onvansertib in Combination With NALIRIFOX for First Line Treatment of Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Kansas Medical Center 21
Large-scale testing (Phase 3)Not Yet RecruitingNCT07711067
What this trial is testing

A Study Comparing Whole-Body Heat Treatment Plus Systemic Therapy to Systemic Therapy Alone, for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma (mPDAC)Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
ElmediX 95
Large-scale testing (Phase 3)Study completedNCT03468335
What this trial is testing

2nd-line Therapy With Nal-IRI After Gem/Nab-pac in Advanced Pancreatic Cancer - Predictive Role of 1st-line Therapy

Who this might be right for
Locally Advanced Pancreatic CancerMetastatic Pancreatic Cancer
AIO-Studien-gGmbH 151
Large-scale testing (Phase 3)Study completedNCT00075686
What this trial is testing

S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer

Who this might be right for
Pancreatic Cancer
SWOG Cancer Research Network 766
Testing effectiveness (Phase 2)Active Not RecruitingNCT06313970
What this trial is testing

First-line Regimen With QL1706 Plus Chemo ± Bev in PDAC Patients

Who this might be right for
Pancreatic Cancer
Fudan University 58
Testing effectiveness (Phase 2)UnknownNCT04415385
What this trial is testing

The Combination of Camrelizumab and Apatinib as Second-line Therapy for Advanced Pancreatic Carcinoma

Who this might be right for
Pancreatic Cancer
Zhejiang Cancer Hospital 48
Testing effectiveness (Phase 2)Looking for participantsNCT06491472
What this trial is testing

Ivonescimab(AK112/SMT112) in Combination With Stereotactic Body Radiation Therapy and Chemotherapy in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT05481476
What this trial is testing

Surufatinib Combined With Sintilimab and AG in First-line Therapy of Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Sun Yat-sen University 32
Testing effectiveness (Phase 2)Looking for participantsNCT07306286
What this trial is testing

Cryoablation Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy

Who this might be right for
Pancreatic Adenocarcinoma Locally Advanced
Ruijin Hospital 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06750861
What this trial is testing

QL1706 Plus Chemotherapy With AG Regime as First-line Treatment of Advanced PDAC

Who this might be right for
Pancreatic Adenocarcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Testing effectiveness (Phase 2)Study completedNCT00068432
What this trial is testing

Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
M.D. Anderson Cancer Center 28
Testing effectiveness (Phase 2)Ended earlyNCT04844970
What this trial is testing

Anamorelin Study for Advanced Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Lahey Clinic 4
Testing effectiveness (Phase 2)Temporarily pausedNCT03417921
What this trial is testing

ABTL0812 in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Ability Pharmaceuticals SL 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT04827953
What this trial is testing

Study to Evaluate the Safety and Efficacy of Treatment With NLM-001 and Standard Chemotherapy Plus Zalifrelimab in Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Nelum Corp 28
Next Page